INSERM UMR 911, Centre de Recherche en Oncologie biologique et en Oncopharmacologie, Faculté de Pharmacie, Aix-Marseille Université, 27 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France.
Cell Mol Life Sci. 2010 Apr;67(7):1089-104. doi: 10.1007/s00018-009-0245-6. Epub 2010 Jan 28.
This review explores various aspects of the interaction between microtubule targeting agents and tubulin, including binding site, affinity, and drug resistance. Starting with the basics of tubulin polymerization and microtubule targeting agent binding, we then highlight how the three-dimensional structures of drug-tubulin complexes obtained on stabilized tubulin are seeded by precise biological and biophysical data. New avenues opened by thermodynamics analysis, high throughput screening, and proteomics for the molecular pharmacology of these drugs are presented. The amount of data generated by biophysical, proteomic and cellular techniques shed more light onto the microtubule-tubulin equilibrium and tubulin-drug interaction. Combining these approaches provides new insight into the mechanism of action of known microtubule interacting agents and rapid in-depth characterization of next generation molecules targeting the interaction between microtubules and associated modulators of their dynamics. This will facilitate the design of improved and/or alternative chemotherapies targeting the microtubule cytoskeleton.
本文综述了微管靶向剂与微管蛋白相互作用的各个方面,包括结合部位、亲和力和耐药性。从微管蛋白聚合和微管靶向剂结合的基础知识开始,我们强调了如何通过精确的生物和生物物理数据来启动稳定的微管上获得的药物-微管蛋白复合物的三维结构。本文还介绍了热力学分析、高通量筛选和蛋白质组学为这些药物的分子药理学开辟的新途径。生物物理、蛋白质组学和细胞技术产生的大量数据进一步阐明了微管-微管蛋白平衡和微管蛋白-药物相互作用。将这些方法结合起来,可以深入了解已知的微管相互作用剂的作用机制,并快速深入地描述下一代靶向微管与相关调节剂相互作用的分子。这将有助于设计针对微管细胞骨架的改进和/或替代化疗药物。